China Focus @ BWB
Sept 10, 2019
Boston Convention and Exhibition Center
Rooms 254 & 255
415 Summer St, Boston, MA 02210
PART OF  Biotech Week Boston



1-on-1 Meeting

Meet the right people and achieve your goals through one-to-one meetings.
*Our Online partnering platform is now open. Registered attendees will receive sign-in information via email.

ABOUT CHINA FOCUS @BWB

China has embraced a vigorously growing healthcare market in the past decade. Ever since joining ICH in 2017, China has seen increased clinical trials and accelerated new drug and device approval. For biotech and MedTech companies outside of China, you need to find the right partners and the right resources to bring your products to China, in order to adapt to the difference in culture, regulation, reimbursement, etc. In the meantime, Chinese biotechs are actively seeking global market entry opportunities and oversea partners.

China Focus @BWB is designed to provide a meaningful platform to inform, inspire, and foster cross-border partnership in life science and healthcare.

Who should attend
  • Investors (VC, PE, investment bank, etc.)
  • Life science innovators and entrepreneurs
  • Biotech & big pharma
  • Medtech (device and diagnostics) manufacturers and distributors
  • Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
  • Healthcare providers
Main topics
  • Regulatory reforms in China and the impact on cross-border partnership
  • Chines biopharma’s strategies to meet the domestic and global needs for innovation
  • Join forces in a global battle again cancer
  • Cell and gene therapy – opportunities for collaboration
  • Winning recipes in a competitive landscape of licensing
What you can get
  • Learn about Chinese life science and healthcare industry
  • Hear about the latest Chinese regulatory reforms and implications
  • Meet with the decision makers in the industry
  • Initiate business conversations that otherwise difficult to start
ATTENDEE DEMOGRAPHICS
at Previous China Focus Events

Attendees

%

Executive Level Attendees

Chinese Companies and Investors

One-to-one meetings

WHAT

TO

EXPECT

PITCH & MATCH

Help you secure 1-on-1 meeting opportunities with your target audience

GENERAL REGISTRATION

Learn about the rising healthcare market opportunity, innovation and investment trend in China from industry leaders from China

INVESTOR REGISTRATION

Qualified investors can request
complimentary registration

MEDIA REGISTRATION

Member of the press can request for a complimentary registration

Download Sample Attendee List from past China Focus events

Download Program from past China Focus events

Agenda

Room Theme Time
254A MyBioGate Global Healthcare Innovation Competition 9 AM – 12:30 PM
Pitch & Match 1:00 PM – 3 PM
254B Exhibition and Partnering 10 AM –   3:30 PM
255 Plenary session 8:30 AM  – 7 PM
Time Plenary session
8:30 AM – 9:10 AM Opening Remark
Keynote: Rise of the Chinese healthcare market and opportunities for investment and collaboration
9:10 AM – 10:10 AM Panel 1: Cross-border partnership in a new era of globalization and innovation
Moderator: Mark Young – Chief Investment Officer, Bridge Point Capital
Panelists:
Lei (Geffrey) Gao – Executive VP/Deputy General Manager, Harbin Pharma
Qingxi (Charles) Wang – Executive Director/ Vice President, CSPC Pharmaceutical Group
Travis McCready – President & CEO, Massachusetts Life Sciences Center
10:10 AM – 10:30 AM Break
10:30 AM – 11:00 AM Featured Talk: Regulatory reforms in China and the impact on cross-border partnership in the healthcare industry
Dan Zhang – Executive Chairman, FMD K&L
11:00 AM – 12:00 PM Panel 2: Chinese biopharma’s diverse strategies to meet the domestic and global needs of innovation
Moderator: Danhui Wang – Founding Partner, Remedeca Partners LLC
Panelists:
Xiyong (Sean) Fu – President, Luye Boston R&D LLC
Lijun Wu – Chief Scientific Officer, Fosun Pharma US
Miguel Forte – CEO, Zelluna Immunotherapy; CCO, International Society for Cell and Gene Therapy
12:00 PM – 1:00 PM Lunch break
1:00 PM – 1:20 PM Featured Talk: Cell and gene therapy in and out of China – opportunities for collaboration
Wei (William) Cao – CEO, Gracell Biotechnologies
1:20 PM – 2:10 PM Panel 3: China’s growing role in a global battle against cancer
Moderator: TBD
Panelists:
Xiangyang (Sean) Zhang – CEO, Hengrui Therapeutics
Wei (William) Cao – CEO, Gracell Biotechnologies
Hua Mu – CMO, Simcere Pharmaceutical Group
2:10 PM – 2:50 PM Chinese company showcase
2:50 PM – 3:10 PM Break
3:10 PM – 4:00 PM Panel 4: Winning recipes in a competitive landscape of licensing – What can we learn from the experiences of recent deal makers?
Moderator: Jie Liu – Managing Director, Torreya Partners
Panelists:
Samuel Murphy – VP and Head of International BD, Salubris Pharmaceuticals
Anna Vardanyan – Executive Director Business Development and Alliance Management, Everest Medicines
Jack Wu – Head of Business Development (USA), Adlai Nortye
4:00 PM – 7:00 PM SIMCERE RECEPTION (complimentary registration needed)
Special Talk: Understanding and curing rare diseases worldwide
     Harvey Lodish – Founding Partner and Professor, Whitehead Institute of Biomedical Research/MIT
Special Talk: PD-1 cancer immunotherapy
     Gordon Freeman – Professor of Medical Oncology, Dana-Farbar Cancer Institute/ Harvard Medical School
Special Talk: The drug regulatory reform and accelerating new drug development in China
     Alex Xu – Chief Scientist, CDE/NMPA
“Simcere Innovation in Boston”
    Shawn Xu – Executive Director, Simcere Innovation, Inc.
Networking (drinks and refreshment provided)
2019 SPEAKERS

(by surnames in alphabetic order)

Wei (William) Cao

Chairman and CEO

Gracell Biotechnologies

Gordon Freeman

Professor of Medical Oncology

Dana-Farber Cancer Center/Harvard Medical School

Miguel Forte

CEO – Zelluna Immunotherapy

CCO – International Society for Cell and Gene Therapy

Xi-Yong-Sean-Fu-2019-Speakers-China-Focus-BWB

Xi-Yong (Sean) Fu

President

Luye Boston R&D LLC

Lei-Geffrey-Gao-2019-Speakers-China-Focus-BWB

Lei (Geffrey) Gao

Executive VP/Deputy General Manager

Harbin Pharma

Jie-Jay-Liu-2019-Speakers-China-Focus-BWB

 

Jie (Jay) Liu

Managing Director

Torreya Partners

Harvey Lodish

Founding Member and Professor

Whitehead Institute of Biomedical Research/MIT

Travis-McCready-2019-Speakers-China-Focus-BWB

Travis McCready

President and CEO

Massachusetts Life Sciences Center

Hua Mu

CMO

Simcere Pharmaceutical Group

Samuel-Murphy-2019-Speakers-China-Focus-BWB

Samuel Murphy

VP and Head of International BD

Salubris Pharmaceuticals

Anna-Vardanyan-2019-Speakers-China-Focus-BWB

Anna Vardanyan

Executive Director Business Development and Alliance Management

Everest Medicines

Danhui-Wang-2019-Speakers-China-Focus-BWB

Danhui Wang

Founding partner

Remedeca Partners LLC

Jack-Wu-2019-Speakers-China-Focus-BWB

Jack Wu

Head of Business Development (USA)

Adlai Nortye

Lijun-Wu-2019-Speakers-China-Focus-BWB

Lijun Wu

CSO

Fosun Pharma US

Xiangbin (Shawn) Xu

Executive Director

Simcere Innovation, Inc.

Zengjun (Alex) Xu

Chief Scientist

CDE/NMPA

Mark Young

Chief Investment Officer

Bridge Point Capital

Dan-Zhang-2019-Speakers-China-Focus-BWB

Dan Zhang

Executive Chairman

FMD K&L

Xiangyang (Sean) Zhang

CEO

Hengrui Therapeutics

Xiangyang (Sean) Zhang

CEO

Hengrui Therapeutics

REGISTRATION

Participating Companies

CONTACT US

3 + 10 =

Registration, Sponsorship and Collaboration (China)

Youwen (Allen) Dai

youwen.dai@mybiogate.com

Registration, Sponsorship and Collaboration (U.S. and Europe)

Xinxin Li

Xinxin.li@mybiogate.com
Speaker, Group Delegation and Presenting Companies

Han Yan

han.yan@mybiogate.com

 

VENUE & ACCOMMODATION
 

Address:

Boston Convention and Exhibition Center
Rooms 254 & 255

415 Summer St, Boston, MA 02210

Phone: 617-954-2000
Fax: 617-954-2299